23 January 2022 - Seven medicines already approved as changes cut as much as a month off approval times. ...
19 January 2022 - The head of Australia's vaccine rollout expects one to two per cent of Australians who remain unvaccinated ...
19 January 2022 - The health technology assessment body has been under pressure from drugmakers and patient groups for years to ...
14 December 2021 - Lung cancer sufferers are still waiting on PHARMAC to reverse a decision made more than a ...
8 December 2021 - Pfizer CEO Albert Bourla said he’s confident the full results from the clinical trials will show that ...
8 December 2021 - The head of the EMA on Tuesday said that it could soon approve the COVID-19 vaccine ...
5 December 2021 - Study from South Africa suggests the fast-spreading Omicron variant might cause less severe illness than its predecessors. ...
6 December 2021 - Diabetes Foundation Aotearoa says PHARMAC's delay funding new diabetes drugs has led to many deaths in Māori ...
1 December 2021 - PDUFA date extended by three months to 5 April 2022. ...
30 November 2021 - CTI BioPharma today announced the U.S. FDA has extended the review period for the new drug application ...
23 November 2021 - FDA PDUFA goal date extended by three months to 28 February 2022. ...
19 November 2021 - Bristol Myers Squibb today announced that the U.S. FDA has extended the review of the new ...
11 November 2021 - Moderna’s coronavirus vaccine could be approved for use as a booster within weeks and the medical ...
9 November 2021 - Janet Woodcock, MD, acting commissioner of the FDA, delivered an upbeat report on biosimilars and generics progress ...
5 November 2021 - The Australian Government has extended the Continued Dispensing emergency arrangements until 30 June 2022, when they ...